IONIS PHARMACEUTICALS INC — Director's Dealing 2020

Sep 2, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IONIS PHARMACEUTICALS INC (IONS)
CIK: 0000874015
Period of Report: 2020-08-31

Reporting Person: Geary Richard S (EVP, Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-31	Common Stock	J	1	$44.455	Acquired	30447	Direct

Footnotes

F1: Reporting 1 share acquired under the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on August 31, 2020. This 1 share may not be sold until February 28, 2021.